PMGC Stock Set to Reverse Split on Tuesday, January 6th (NASDAQ:ELAB)

PMGC Holdings Inc. (NASDAQ:ELAB)’s stock is scheduled to reverse split on the morning of Tuesday, January 6th. The 1-4 reverse split was announced on Friday, January 2nd. The number of shares owned by shareholders will be adjusted after the market closes on Monday, January 5th.

PMGC Price Performance

ELAB stock traded down $0.06 during mid-day trading on Friday, reaching $1.42. 478,161 shares of the stock traded hands, compared to its average volume of 998,008. The stock’s fifty day moving average is $4.34 and its 200-day moving average is $5.86. PMGC has a 52-week low of $1.25 and a 52-week high of $99.72.

PMGC (NASDAQ:ELAB) last issued its quarterly earnings results on Friday, November 14th. The company reported ($4.95) earnings per share for the quarter. The firm had revenue of $0.29 million during the quarter.

Analysts Set New Price Targets

ELAB has been the topic of a number of recent analyst reports. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of PMGC in a research report on Monday. Wall Street Zen upgraded PMGC to a “sell” rating in a research note on Saturday, October 25th. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock has a consensus rating of “Sell”.

About PMGC

Elevai Labs, Inc, a skincare development company, designs, manufactures, and markets skincare products. Its products include Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. The company was formerly known as Reactive Medical Labs Inc and changed its name to Elevai Labs, Inc in December 2021. Elevai Labs, Inc was incorporated in 2020 and is based in Newport Beach, California.